BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:QLH2405 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of QLH2405\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07489599-775@assetmemo.bio
DTSTAMP:20261121T005445Z
DTSTART;VALUE=DATE:20270331
DTEND;VALUE=DATE:20270401
SUMMARY:QLH2405: Phase 1 readout est. (NCT07489599)
DESCRIPTION:QLH2405\, phase 1\, Alzheimer's Disease.\nStudy: A Study of QLH
 2405 in Healthy Participants and Participants With Mild Cognitive Impairme
 nt Due to Alzheimer's Disease and Mild Alzheimer's Disease\nEstimated prim
 ary completion: March 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/qlh2405#upcoming-events\nRegistry record: https://clinicaltrials.go
 v/study/NCT07489599
URL:https://assetmemo.bio/drug/qlh2405#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
